AnaptysBio director Renton Hollings disposes of USD 249,371 common shares

• Director Renton Hollings sold 5,000 AnaptysBio common shares on Oct. 1, 2026 at USD 49.8743.
• He exercised options for 5,000 shares the same day at USD 18.03.
• Directly held common shares fell to 10,995 after the transactions.
• Remaining vested options cover 10,000 shares, expiring Feb. 23, 2027.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AnaptysBio Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001187333-26-000004), on October 02, 2026, and is solely responsible for the information contained therein.